> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Remote Interactive Evaluation Guidance
- URL: https://www.fdaweb.com/remote-interactive-evaluation-guidance/
- Published: 2023-10-25T12:00:00.000Z
- Updated: 2026-09-14T14:14:22.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5155646

FDA has published a draft guidance, *Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities*, describing how the agency requests and conducts voluntary remote interactive evaluations at facilities where drugs are manufactured, processed, packed, compounded, or held, and at drug facilities covered under the agency’s bioresearch monitoring program. The [document](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/remote-interactive-evaluations-drug-manufacturing-and-bioresearch-monitoring-facilities?ref=fdaweb.com) says FDA may consider using a remote interactive evaluation for any of the inspection programs described in the guidance.

The guidance contains an Introduction, Background, Planning a Remote Interactive Evaluation, Conducting a Remote Interactive Evaluation, Concluding a Remote Interactive Evaluation, and Timeframes Following Completion of a Remote Interactive Evaluation.